Skip to main content

Table 4 Agreement between CLART and LA with respect to single and multiple infections in 401 women with abnormal cytology

From: Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample study

LA

CLART

Total

Single infection

Multiple infection

No HPV genotypea

Single infection

89

19

13

121 (30%)

Multiple infection

40

216

3

259 (65%)

No HPV genotype a

1

0

20

21 (5%)

Total

130 (32%)

235 (59%)

36 (9%)

401 (100%)

  1. aOr genotypes not detectable by both CLART and LA (CLART: 43, 44, 85, 89; LA: 55, 64, 67, 69, IS39, CP6108).